178
Participants
Start Date
August 7, 2020
Primary Completion Date
July 4, 2027
Study Completion Date
July 3, 2028
SEA-CD70
Given into the vein (IV; intravenously) on Days 1 and 15 of each treatment cycle
azacitidine
75mg/m\^2 injected under the skin (SC; subcutaneous) or given into the vein (IV; intravenously) on Days 1 through 7 of each treatment cycle.
Venetoclax
400 mg /day PO, continuously; administered with ramping
RECRUITING
Columbia University Irving Medical Center, New York
RECRUITING
CUIMC Research Pharmacy, New York
RECRUITING
The New York and Presbyterian Hospital, New York
RECRUITING
Hollings Cancer Center, Charleston
RECRUITING
Medical University of South Carolina- Ashley River Tower, Charleston
RECRUITING
Medical University of South Carolina- Investigational Drug Services, Charleston
RECRUITING
Medical University of South Carolina- University Hospital, Charleston
ACTIVE_NOT_RECRUITING
University of Alabama at Birmingham, Birmingham
ACTIVE_NOT_RECRUITING
University of Alabama at Birmingham, Birmingham
ACTIVE_NOT_RECRUITING
Dept. of Medicine, UAB ONeal Comprehensive Cancer Center, Birmingham
ACTIVE_NOT_RECRUITING
ONeal Comprehensive Cancer Center at UAB, Birmingham
RECRUITING
Norton Cancer Institute, St. Matthews Campus, Attn. Becky Champion, PharmD, Louisville
RECRUITING
Norton Cancer Institute, St. Matthews Campus, Louisville
RECRUITING
Norton Women & Children's Hospital, Louisville
RECRUITING
The Ohio State University Wexner Medical Center/James Cancer Hospital, Columbus
RECRUITING
University Hospitals Cleveland Medical Center, Cleveland
RECRUITING
Cleveland Clinic, Cleveland
RECRUITING
Karmanos Cancer Institute, Detroit
RECRUITING
Karmanos Cancer Institute Weisberg Cancer Treatment Center, Farmington Hills
RECRUITING
The University of Kansas Cancer Center - Lee's Summit, Lee's Summit
RECRUITING
The University of Kansas Cancer Center - Medical Oncology Clinic, Kansas City
RECRUITING
The University of Kansas Cancer Center - Radiation Oncology Clinic, Kansas City
RECRUITING
The University of Kansas Cancer Center -North, Kansas City
RECRUITING
The University of Kansas Hospital, Kansas City
RECRUITING
University of Kansas Hospital Cambridge North Tower A, Kansas City
RECRUITING
University of Kansas Medical center Medical office building, Kansas City
RECRUITING
University of Kansas Medical Center Research Institute, Kansas City
RECRUITING
The University of Kansas Cancer Center ,Investigational Drug Services, Fairway
RECRUITING
The University of Kansas Clinical Research Center, Fairway
RECRUITING
The University of Kansas Cancer Center, Westwood
RECRUITING
The University of Kansas Cancer Center - Overland Park, Overland Park
RECRUITING
The University of Kansas Cancer Center - Indian Creek Campus, Overland Park
RECRUITING
Baylor Research Institute, Dallas
RECRUITING
Baylor University Medical Center, Investigational Drug Services, Department of Pharmacy, Dallas
RECRUITING
Baylor University Medical Center, Dallas
RECRUITING
Houston Methodist Hospital, Houston
ACTIVE_NOT_RECRUITING
The University of Texas MD Anderson Cancer Center, Houston
RECRUITING
Colorado Blood Cancer Institute, Lab, Denver
RECRUITING
Colorado Blood Cancer Institute, Denver
RECRUITING
Presbyterian/St. Luke's Medical Center, Denver
RECRUITING
Ronald Reagan UCLA Medical Center, Los Angeles
RECRUITING
UCLA Hematology-Oncology Clinic, Los Angeles
RECRUITING
City of Hope (City of Hope National Medical Center, City of Hope Medical Center), Duarte
RECRUITING
IP Address: City of Hope Investigational Drug Services(IDS), Duarte
RECRUITING
Swedish Cancer Institute, Seattle
RECRUITING
Swedish Medical Center, Seattle
RECRUITING
Massachusetts General Hospital, Boston
RECRUITING
Beth Israel Deaconess Medical Center, Boston
RECRUITING
Dana Farber/Mass General Brigham Cancer Care, Inc, Boston
NOT_YET_RECRUITING
National Cancer Center Hospital East, Kashiwa
NOT_YET_RECRUITING
Nippon Medical School Hospital, Bunkyo-ku
NOT_YET_RECRUITING
Yamagata University Hospital, Yamagata
RECRUITING
Pharmacy - UMC Utrecht t.a.v. Apotheek KGO, Utrecht
RECRUITING
University Medical Center (UMC) Utrecht, Utrecht
Seagen, a wholly owned subsidiary of Pfizer
INDUSTRY